A member of the Rutgers Institute for Health, Health Care Policy, and Aging Research served as lead author of a recent study showing the potential of telehealth services to address health care disruption among individuals with multiple sclerosis.
In tackling high rates of health care disruption among individuals with multiple sclerosis (MS), a study led by investigators from the Rutgers Institute for Health, Health Care Policy, and Aging Research (IFH) showed that people with MS were more likely to utilize telehealth services than people without the condition.
The study was published in Archives of Physical Medicine and Rehabilitation, with research also conducted by investigators of Kessler Foundation, Rutgers New Jersey Medical School, and New York University
“The findings suggest that telehealth services were well liked during the pandemic. Because many individuals with MS have physical disability that may make travel more difficult, temporary expansions of telehealth coverage should be made permanent after the pandemic in order to expand access and reduce health care disparities,” said lead study author Michelle Chen, a core member of Rutgers IFH, and neurology instructor at Robert Wood Johnson Medical School.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More